by Alex Watkins ONeill | Mar 3, 2026 | Content
On December 30, 2025, the Federal Register indicated that the Drug Enforcement Administration (DEA) and the Department of Health and Human Services (HHS) are jointly issuing a fourth temporary extension rule (the “Fourth Temporary Extension Rule”), preserving existing...
by Alex Watkins ONeill | Feb 24, 2026 | Content
During 2025, the Knox County Regional Forensic Center identified a new synthetic opioid in three East Tennessee counties. While limited information is available on the new substance, here is what is known about N-Propionitrile Chlorphine, which is also known by the...
by Alex Watkins ONeill | Feb 17, 2026 | Content
Emerging but inconclusive data suggest modest recent declines in alcohol use and binge drinking among US adults, notably ages 35–50, with similar patterns in some European countries. Potential drivers include economic pressures, increased awareness of health risks...
by Alex Watkins ONeill | Feb 10, 2026 | Content
Using the CDC Wide-ranging ONline Data for Epidemiologic Research (WONDER) data set, this study identified methamphetamine-related deaths among US residents aged 15 or older from 2005 to 2023 and calculated mortality rates over time for the 9 US Census Divisions. ...
by Alex Watkins ONeill | Feb 3, 2026 | Content
New research from Oregon Health & Science University found that the rate of opioid use during pregnancy has risen two-fold over the past decade. The study, published today in the Journal of Addiction Medicine, also identified significantly increased risks of...
by Alex Watkins ONeill | Jan 26, 2026 | Content
An Addiction Policy Forum roundup summarizes 10 recent scientific developments reshaping our understanding of substance use disorders. Advances include promising work with GLP-1 agonists and neuromodulation, evidence that contingency management reduces mortality for...
Recent Comments